Congenital Heart Academy

Perfusfind S.L.

    Congenital Heart Academy    

Perfusfind S.L.

    Congenital Heart Academy    

Perfusfind S.L.

        Congenital Heart Academy    

Perfusfind S.L.

Join us at the as we present cutting edge inpatient and operative strategies for improving neurodevelopmental outcomes for children with congenital heart disease. Presented by members of the NeuroCardiac Critical Care Program at and others, free of charge on September 9th, 2024.  

Perfusfind S.L.

                                                    Congenital Heart Academy    

Perfusfind S.L.

Simpósio Moving Forward in Heart Failure Management: breaktrough devices and évidence - 5th Advances in Heart Failure 2022        

Perfusfind S.L.

      Congenital Heart Academy    

Perfusfind S.L.

III ENCUENTRO EN ESPAÑOL de la Congenital Heart Academy    Congenital Heart Academy    

Perfusfind S.L.

Echo-morphological comparisons in the functionally single ventricle   Echo-morphological comparisons in the hypoplasia of the left heart     Pulmonary atresia with intact ventricular septum   Heart with Isomerism   Ebstein Special Edition Congenital Heart Academy    

Perfusfind S.L.

This time around we are discussing very interesting work by  et al from CHU, Lille, France in the field of minimal invasive congenital cardiac surgery.     Levosimendan as a primary inotrope after Pediatric cardiac surgery and will be discussing the work of Joshi R K et from Sir Ganga Ram..